title: Letter from the editor.
authors.affiliation: a Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Ellis
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D003141:Communicable Diseases / Q000191:economics* / Q000453:epidemiology*; D004812:Epidemiologic Methods; D006801:Humans; D014611:Vaccination / Q000191:economics / Q000379:methods*; D014612:Vaccines / Q000009:adverse effects / Q000276:immunology* / Q000302:isolation & purification*
chemical_list: D014612:Vaccines